The GoodRx Prescription Savings Blog

The latest updates on prescription drugs and ways to save from the GoodRx medical team

Recall: Generic Neurontin (Gabapentin)

by The GoodRx Pharmacist on December 1, 2014 at 4:53 am

Aurobindo, one manufacturer of generic gabapentin, has issued a voluntary recall of one lot of gabpentin capsules. Gabapentin (brand name Neurontin) is most commonly used to treat nerve pain, especially in diabetic patients with neuropathy, and seizure disorders.

This is a Class I recall, which means there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death. Class I recalls are the most serious; Class II and III are both more common and mean the affected drug is less likely to cause adverse effects.

Why were the gabapentin capsules recalled?

The affected lot of gabapentin was found to contain some empty capsules. An empty capsule would mean a missed dose, which could result in decreased effectiveness, short-term withdrawal, or seizure (if you’re using gabapentin to prevent them).

Which products are affected?

In this recall only one manufacturer and one lot were affected:

Drug: gabapentin 300 mg capsules, 100-count bottle
Manufacturer: Aurobindo Pharma USA (Northstar Rx LLC)
Lot: GESB14011-A
Expiration date: 12/2015
National Drug Code (NDC): 16714-662-01

You can also see the packaging of the affected product here.
What is being done about the recall?

Aurobindo Pharma USA is notifying its distributors and customers using recall letters. They are arranging for a return of all recalled medication.

Many pharmacies are also placing calls to patients who have received the affected gabapentin 300 mg capsules within a certain date range.

How do I reach Aurobindo if I have questions?

You can contact the manufacturer via telephone or email with any questions regarding the recall.

You can call the Aurobindo Pharmacovigilance group at (732) 839-9400, option 2, Monday through Friday between 8:30 am and 5:00 pm, EST, or contact them via email at

You can also find more information in the full FDA announcement here.

Copyright ©2015 GoodRx, Inc.

This information is for informational purposes only and is not meant to be a substitute for professional medical advice, diagnosis or treatment. GoodRx is not offering advice, recommending or endorsing any specific prescription drug, pharmacy or other information on the site. GoodRx provides no warranty for any of the pricing data or other information. Please seek medical advice before starting, changing or terminating any medical treatment. Third party logos, trademarks, brand names and images contained on are for demonstration purposes only and are owned by their respective rights holders, who are not affiliated with this Site.